These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5486372)

  • 1. [Post-desferrioxamine urinary iron in iron-overload states].
    Santiago Corchado M; Ribas Ozonas B
    Rev Clin Esp; 1970 Jul; 118(2):151-8. PubMed ID: 5486372
    [No Abstract]   [Full Text] [Related]  

  • 2. Desferrioxamine utilisation for the quantitation of iron excess. Study of 24 patients having idiopathic haemochromatosis.
    Saddi R; Feingold J; Degrese CH; Fagard R
    Biomedicine; 1978; 28(1):41-7. PubMed ID: 667275
    [No Abstract]   [Full Text] [Related]  

  • 3. Four-hour measurement of urinary iron excretion after deferoxine treatment: a rapid, simple method for study of iron excretion.
    Bonkovsky HL; Weber R; Aaron L
    Am J Gastroenterol; 1990 May; 85(5):554-7. PubMed ID: 2337058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The diagnostic value of the desferrioxamine B test in the latent form of primary idiopathic hemochromatosis].
    Michaelis D; Takác A; Bruns W
    Acta Biol Med Ger; 1966; 16(3):300-8. PubMed ID: 4964937
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of desferrioxamine-induced sideruria and measurement of labile iron store as indices of body iron status.
    Singh AK
    J Med; 1971; 2(6):345-62. PubMed ID: 5292126
    [No Abstract]   [Full Text] [Related]  

  • 6. Storage iron and desferrioxamine.
    Fielding J
    Proc R Soc Med; 1970 Dec; 63(12):1218-21. PubMed ID: 5490766
    [No Abstract]   [Full Text] [Related]  

  • 7. Iron stores in alcohol abusers. II. As measured with the desferrioxamine test.
    Lundvall O; Weinfeld A
    Acta Med Scand; 1969 Apr; 185(4):271-7. PubMed ID: 5806336
    [No Abstract]   [Full Text] [Related]  

  • 8. [Respective variations of iron in blood and urine in cirrhotic and alcoholic patients after a desferrioxamine test].
    Aron E; Weill JD; Galand A; Domenech
    Arch Fr Mal App Dig; 1966 Dec; 55(12):1159-66. PubMed ID: 5986599
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemochromatosis].
    Phlippen R
    Munch Med Wochenschr; 1972 Feb; 114(5):147-9. PubMed ID: 5066916
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of ascorbic acid on desferrioxamine-induced urinary iron excretion in idiopathic hemochromatosis.
    Conte D; Brunelli L; Ferrario L; Mandelli C; Quatrini M; Velio P; Bianchi PA
    Acta Haematol; 1984; 72(2):117-20. PubMed ID: 6437113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Deferoxamine-B test. Evaluation of the organism's iron content by loading with a ferriuretic chelate].
    Bennike T; Dyerberg J
    Ugeskr Laeger; 1967 Sep; 129(36):1139-43. PubMed ID: 5598852
    [No Abstract]   [Full Text] [Related]  

  • 12. Iron overload in haemochromatosis.
    Dymock IW; Miller JP; Godfrey BE; Williams R
    Proc R Soc Med; 1970 Dec; 63(12):1227-30. PubMed ID: 5490768
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on iron metabolism with desferrioxamine in man. Experimental and clinical studies.
    Hedenberg L
    Scand J Haematol Suppl; 1969; 6():5-86. PubMed ID: 5259199
    [No Abstract]   [Full Text] [Related]  

  • 14. Desferrioxamine induced urinary iron excretion in thalassemia.
    Dubey AP; Kumar S; Choudhury P; Talukdar B; Puri RK
    Indian Pediatr; 1993 Jun; 30(6):775-8. PubMed ID: 8132258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The desferrioxamine test in patients with kidney diseases].
    Pannacciulli I; Paravidino GF; Siccardi G
    Minerva Med; 1971 Feb; 62(15):683-90. PubMed ID: 5549142
    [No Abstract]   [Full Text] [Related]  

  • 16. [Iron and copper metabolism in hemochromatosis and Wilson's disease. Studies on relatives of patients].
    Petera V; Lahn V; Virt S; Voleníková L; Kohout J
    Z Gesamte Inn Med; 1969 May; 24(10):315-9. PubMed ID: 5807434
    [No Abstract]   [Full Text] [Related]  

  • 17. Twenty-four hour desferrioxamine test in normal, iron deficient and hypersideraemic (both hypersiderotic and non-hypersiderotic) subjects.
    Scuro LA; Dobrilla G; Lechi A; Innecco A; Cavallini G
    Panminerva Med; 1967 Jun; 9(6):207-11. PubMed ID: 6074997
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of ascorbic acid on desferrioxamine-induced siderinuria].
    Bosello O; Mengoli C; Rossi G
    Fracastoro; 1971; 64(5):310-9. PubMed ID: 5151104
    [No Abstract]   [Full Text] [Related]  

  • 19. [Iron-overload in patients on maintenance hemodialysis: diagnostic criteria, indications and treatment by desferrioxamine (author's transl)].
    Simon P; Bonn F; Guezennec M; Tanquerel T; Ksang
    Nephrologie; 1981; 2(4):165-70. PubMed ID: 7329501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On the usefulness of iron kinetics studied with Fe59 in the differential diagnosis of idiopathic siderochromatosis and that secondary to liver diseases].
    Scandellari C; Dobrilla G; Bosello O; Cavallini G; Lo Cascio V; Cartei G
    Acta Isot (Padova); 1967 Dec; 7(1):117-34. PubMed ID: 5612067
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.